-
Company Insights
New![]()
Innovation and Patenting activity of PPD Inc Q3 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of PPD Inc Q3 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be delivered...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Brexanolone in Tinnitus
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Brexanolone in TinnitusDrug Details:Brexanolone (Zulresso) is a mixture of allopregnanolone and sulfobutylether-beta-cyclodextrin, acts as an anti-depressant....
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – LPCN-1154 in Post Partum Depression (Maternal Depression / Postnatal Depression)
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Brexanolone in Post Partum Depression (Maternal Depression / Postnatal Depression) Drug Details: Brexanolone is...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Deuterated Etifoxine in Major Depressive Disorder
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Deuterated Etifoxine in Major Depressive Disorder Drug Details: Deuterated etifoxine is under development for the...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Deuterated Etifoxine in Treatment Resistant Depression
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Deuterated Etifoxine in Treatment Resistant Depression Drug Details: Deuterated etifoxine is under development for the...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Zuranolone in Bipolar Disorder (Manic Depression)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Zuranolone in Bipolar Disorder (Manic Depression) Drug Details: Zuranolone (Zurzuvae) is a neuroactive steroid gamma-aminobutyric...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Deuterated etifoxine in Generalized Anxiety Disorder (GAD)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Deuterated etifoxine in Generalized Anxiety Disorder (GAD) Drug Details: Deuterated etifoxine is under development for...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Zuranolone in Treatment Resistant Depression
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Zuranolone in Treatment Resistant Depression Drug Details: Zuranolone (Zurzuvae) is a neuroactive steroid gamma-aminobutyric acid...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Deuterated Etifoxine in Post Partum Depression (Maternal Depression / Postnatal Depression)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Deuterated Etifoxine in Post Partum Depression (Maternal Depression / Postnatal Depression) Drug Details: Deuterated etifoxine...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Deuterated Etifoxine in Post-Traumatic Stress Disorder (PTSD)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Deuterated Etifoxine in Post-Traumatic Stress Disorder (PTSD) Drug Details: Deuterated etifoxine is under development for...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Zuranolone in Generalized Anxiety Disorder (GAD)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Zuranolone in Generalized Anxiety Disorder (GAD) Drug Details: Zuranolone (Zurzuvae) is a neuroactive steroid gamma-aminobutyric...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Ganaxolone in Status Epilepticus
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Ganaxolone in Status Epilepticus Drug Details:Ganaxolone (Ztalmy) is a synthetic analog of the neuroactive steroid allopregnanolone...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Ganaxolone in Tuberous Sclerosis
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Ganaxolone in Tuberous SclerosisDrug Details:Ganaxolone (Ztalmy) is a synthetic analog of the neuroactive steroid allopregnanolone acts...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Ganaxolone in Lennox-Gastaut Syndrome
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Ganaxolone in Lennox-Gastaut Syndrome Drug Details: Ganaxolone (Ztalmy) is a synthetic analog of the neuroactive...
-
Product Insights
![]()
TMC PPD – Torbothie Residential Community – North Lanarkshire
Equip yourself with the essential tools needed to make informed and profitable decisions with our TMC PPD - Torbothie Residential Community - North Lanarkshire report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Product Insights
![]()
PPD of WV One – Greenbrier Synthetic Fuel Plant – West Virginia
Equip yourself with the essential tools needed to make informed and profitable decisions with our PPD of WV One - Greenbrier Synthetic Fuel Plant - West Virginia report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story:...
-
Product Insights
![]()
Clinical Trials – Precision and Personalized Medicine
This report provides analysis of clinical research involving precision and personalized medicines and identifies trends throughout the years. The terms precision and personalized medicine are often used interchangeably as they refer to similar types of treatment. They both define the stratification of patients within a disease segment using their genomic and phenotypic variations to find targeted therapies. This is an alternative to the traditional process of drug design, which typically follows a one-size-fits all approach. Precision and personalized medicine is...
-
Company Profile
![]()
PPD Inc – Company Profile
PPD Inc (PPD) is a pharmaceutical company that carries out the drug development, laboratory and lifecycle management services. It offers clinical development and laboratories solution. The company's clinical services include early development, clinical trial management, biostatics, peri- and post-approval, site and patient-centric solutions, product development and consulting, technology and innovation, decentralized clinical trials, information security and preclarus, among others. PPD's laboratories services include bioanalytical lab, bioanalytical lab experience and expertise, biomarker lab, biomarker lab resource, central lab, central lab capabilities,...
Add to Basket -
Sector Analysis
![]()
Mergers and Acquisitions (M&A) in the Contract Manufacturing Industry – Implications and Outlook – 2023 Edition
M and A In Pharmaceutical Contract Manufacturing Industry Report Overview During 2018–22, contract manufacturing organization (CMO) merger and acquisition (M&A) deal activity increased, and the targeted manufacturers have adopted specialized capabilities such as controlled substance and containment manufacture. Despite considerable macroeconomic challenges for pharma manufacturers, 2021–22 witnessed strong M&A activity and CMO valuations, although there was a slight decline in CMO M&A activity in 2022 due to rising inflation and interest rates. The Mergers and Acquisitions (M&A) in the Contract...
-
Company Profile
![]()
Pharmaceutical Product Development LLC – Company Profile
Pharmaceutical Product Development LLC (PPD) is a contract research organization, which offers drug discovery, development and lifecycle management services. The company’s service portfolio encompasses early development, peri- and post-approval, clinical development, laboratories and consulting, and site and patient services, among others. It has expertise in clinical trials in various therapy areas including cardiovascular system, critical care, dermatology, gastroenterology, hematology, cancer, infectious diseases, ophthalmology, respiratory, endocrine systems, metabolism, rare diseases and urology, among others. PPD serves pharmaceutical, biotechnology, medical device, and...
Add to Basket
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.